{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:11:51Z","timestamp":1789229511545,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,27]]},"DOI":"10.7759\/cureus.93365","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:13:31Z","timestamp":1759022011000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Clinical Factors Between Recurrent and Non-recurrent Atrial Fibrillation Within One Year After Catheter Ablation by the Same Operators at a Regional Core Hospital in Japan"],"prefix":"10.7759","author":[{"given":"Toshio","family":"Katagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Inage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e328358554b","article-title":"Risk factors for atrial fibrillation recurrence: a literature review","volume":"15","author":"Vizzardi E","year":"2014","unstructured":"Vizzardi E, Curnis A, Latini MG, et al.. Risk factors for atrial fibrillation recurrence: a literature review. J Cardiovasc Med (Hagerstown). 2014, 15:235-53. 10.2459\/JCM.0b013e328358554b","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.114.001759","article-title":"Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials","volume":"7","author":"Wynn GJ","year":"2014","unstructured":"Wynn GJ, Das M, Bonnett LJ, Panikker S, Wong T, Gupta D. Efficacy of catheter ablation for persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized and nonrandomized controlled trials. Circ Arrhythm Electrophysiol. 2014, 7:841-52. 10.1161\/CIRCEP.114.001759","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309781","article-title":"Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial","volume":"103","author":"Nielsen JC","year":"2017","unstructured":"Nielsen JC, Johannessen A, Raatikainen P, et al.. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017, 103:368-76. 10.1136\/heartjnl-2016-309781","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2021.1892490","article-title":"Predictors of recurrent atrial fibrillation following catheter ablation","volume":"19","author":"Mohanty S","year":"2021","unstructured":"Mohanty S, Della Rocca DG, Gianni C, Trivedi C, Mayedo AQ, MacDonald B, Natale A. Predictors of recurrent atrial fibrillation following catheter ablation. Expert Rev Cardiovasc Ther. 2021, 19:237-46. 10.1080\/14779072.2021.1892490","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2023.05.038","article-title":"Efficacy of early catheter ablation for\u00a0atrial fibrillation after admission for\u00a0heart\u00a0failure","volume":"9","author":"Sakamoto K","year":"2023","unstructured":"Sakamoto K, Tohyama T, Ide T, et al.. Efficacy of early catheter ablation for\u00a0atrial fibrillation after admission for\u00a0heart\u00a0failure. JACC Clin Electrophysiol. 2023, 9:1948-59. 10.1016\/j.jacep.2023.05.038","journal-title":"JACC Clin Electrophysiol"},{"key":"ref7","article-title":"Recurrent atrial fibrillation after catheter ablation: considerations for repeat ablation and strategies to optimize success","volume":"9","author":"Darby AE","year":"2016","unstructured":"Darby AE. Recurrent atrial fibrillation after catheter ablation: considerations for repeat ablation and strategies to optimize success. J Atr Fibrillation. 2016, 9:1427.","journal-title":"J Atr Fibrillation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-21-0326","article-title":"Different determinants of the recurrence of atrial fibrillation and adverse clinical events in the mid-term period after atrial fibrillation ablation","volume":"86","author":"Watanabe R","year":"2022","unstructured":"Watanabe R, Nagashima K, Wakamatsu Y, et al.. Different determinants of the recurrence of atrial fibrillation and adverse clinical events in the mid-term period after atrial fibrillation ablation. Circ J. 2022, 86:233-42. 10.1253\/circj.CJ-21-0326","journal-title":"Circ J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.05.012","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"14","author":"Calkins H","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, et al.. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017, 14:e275-444. 10.1016\/j.hrthm.2017.05.012","journal-title":"Heart Rhythm"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001207","article-title":"Correction to: 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","year":"2024","unstructured":"Correction to. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024, 149:e167. 10.1161\/CIR.0000000000001207","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0637","article-title":"JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias","volume":"85","author":"Nogami A","year":"2021","unstructured":"Nogami A, Kurita T, Abe H, et al.. JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. Circ J. 2021, 85:1104-244. 10.1253\/circj.CJ-20-0637","journal-title":"Circ J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010209","article-title":"Atrial fibrosis in atrial fibrillation: mechanistic insights, diagnostic challenges, and emerging therapeutic targets","volume":"26","author":"Karakasis P","year":"2025","unstructured":"Karakasis P, Theofilis P, Vlachakis PK, Korantzopoulos P, Patoulias D, Antoniadis AP, Fragakis N. Atrial fibrosis in atrial fibrillation: mechanistic insights, diagnostic challenges, and emerging therapeutic targets. Int J Mol Sci. 2025, 26:209. 10.3390\/ijms26010209","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2008.01.031","article-title":"Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation","volume":"5","author":"Themistoclakis S","year":"2008","unstructured":"Themistoclakis S, Schweikert RA, Saliba WI, et al.. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm. 2008, 5:679-85. 10.1016\/j.hrthm.2008.01.031","journal-title":"Heart Rhythm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.064","article-title":"Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation","volume":"51","author":"Burstein B","year":"2008","unstructured":"Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008, 51:802-9. 10.1016\/j.jacc.2007.09.064","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut265","article-title":"Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections","volume":"16","author":"Yamaguchi T","year":"2014","unstructured":"Yamaguchi T, Tsuchiya T, Nagamoto Y, Miyamoto K, Murotani K, Okishige K, Takahashi N. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections. Europace. 2014, 16:511-20. 10.1093\/europace\/eut265","journal-title":"Europace"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2020.4842","article-title":"Atrial fibrosis underlying atrial fibrillation (Review)","volume":"47","author":"Li CY","year":"2021","unstructured":"Li CY, Zhang JR, Hu WN, Li SN. Atrial fibrosis underlying atrial fibrillation (Review). Int J Mol Med. 2021, 47:10.3892\/ijmm.2020.4842","journal-title":"Int J Mol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2009.09.001","article-title":"Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation","volume":"48","author":"Pellman J","year":"2010","unstructured":"Pellman J, Lyon RC, Sheikh F. Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation. J Mol Cell Cardiol. 2010, 48:461-7. 10.1016\/j.yjmcc.2009.09.001","journal-title":"J Mol Cell Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.02.004","article-title":"Fibroblast-restricted inflammasome activation promotes atrial fibrillation and heart failure with diastolic dysfunction","volume":"10","author":"Li L","year":"2025","unstructured":"Li L, Coarfa C, Yuan Y, et al.. Fibroblast-restricted inflammasome activation promotes atrial fibrillation and heart failure with diastolic dysfunction. JACC Basic Transl Sci. 2025, 10:101244. 10.1016\/j.jacbts.2025.02.004","journal-title":"JACC Basic Transl Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602014","article-title":"Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation","volume":"374","author":"Kuck KH","year":"2016","unstructured":"Kuck KH, Brugada J, F\u00fcrnkranz A, et al.. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016, 374:2235-45. 10.1056\/NEJMoa1602014","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.23722","article-title":"Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation. The CAPLA randomized clinical trial","volume":"329","author":"Kistler PM","year":"2023","unstructured":"Kistler PM, Chieng D, Sugumar H, et al.. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation. The CAPLA randomized clinical trial. JAMA. 2023, 329:127-35. 10.1001\/jama.2022.23722","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.047266","article-title":"Renal function after catheter ablation of atrial fibrillation","volume":"124","author":"Takahashi Y","year":"2011","unstructured":"Takahashi Y, Takahashi A, Kuwahara T, et al.. Renal function after catheter ablation of atrial fibrillation. Circulation. 2011, 124:2380-7. 10.1161\/CIRCULATIONAHA.111.047266","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241449","article-title":"Renal function and outcomes in atrial fibrillation patients after catheter ablation","volume":"15","author":"Kawaji T","year":"2020","unstructured":"Kawaji T, Shizuta S, Aizawa T, et al.. Renal function and outcomes in atrial fibrillation patients after catheter ablation. PLoS One. 2020, 15:e0241449. 10.1371\/journal.pone.0241449","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.06.031","article-title":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study","volume":"158","author":"Watanabe H","year":"2009","unstructured":"Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J. 2009, 158:629-36. 10.1016\/j.ahj.2009.06.031","journal-title":"Am Heart J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof P","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al.. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020, 383:1305-16. 10.1056\/NEJMoa2019422","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013204","article-title":"Five-year change in the renal function after catheter ablation of atrial fibrillation","volume":"8","author":"Park JW","year":"2019","unstructured":"Park JW, Yang PS, Bae HJ, et al.. Five-year change in the renal function after catheter ablation of atrial fibrillation. J Am Heart Assoc. 2019, 8:e013204. 10.1161\/JAHA.119.013204","journal-title":"J Am Heart Assoc"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2013.0116","article-title":"Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation","volume":"21","author":"Li M","year":"2014","unstructured":"Li M, Liu T, Luo D, Li G. Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablation. Cardiol J. 2014, 21:89-95. 10.5603\/CJ.a2013.0116","journal-title":"Cardiol J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14173","article-title":"Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta-analysis","volume":"75","author":"Lee WC","year":"2021","unstructured":"Lee WC, Wu PJ, Fang CY, Chen HC, Chen MC. Impact of chronic kidney disease on atrial fibrillation recurrence following radiofrequency and cryoballoon ablation: A meta-analysis. Int J Clin Pract. 2021, 75:e14173. 10.1111\/ijcp.14173","journal-title":"Int J Clin Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01726","article-title":"Chronic kidney disease increases atrial fibrillation inducibility: involvement of inflammation, atrial fibrosis, and connexins","volume":"9","author":"Qiu H","year":"2018","unstructured":"Qiu H, Ji C, Liu W, et al.. Chronic kidney disease increases atrial fibrillation inducibility: involvement of inflammation, atrial fibrosis, and connexins. Front Physiol. 2018, 9:1726. 10.3389\/fphys.2018.01726","journal-title":"Front Physiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011466","article-title":"Chronic kidney disease induces proarrhythmic remodeling","volume":"16","author":"King BM","year":"2023","unstructured":"King BM, Mintz S, Lin X, Morley GE, Schlamp F, Khodadadi-Jamayran A, Fishman GI. Chronic kidney disease induces proarrhythmic remodeling. Circ Arrhythm Electrophysiol. 2023, 16:e011466. 10.1161\/CIRCEP.122.011466","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-024-00661-5","article-title":"Impact of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in type 2 diabetes mellitus: a meta-analysis of reconstructed Kaplan-Meier curves with trial sequential analysis","volume":"24","author":"Soliman Y","year":"2024","unstructured":"Soliman Y, Abuelazm M, Amer BE, et al.. Impact of SGLT2 inhibitors on atrial fibrillation recurrence after catheter ablation in type 2 diabetes mellitus: a meta-analysis of reconstructed Kaplan-Meier curves with trial sequential analysis. Am J Cardiovasc Drugs. 2024, 24:629-40. 10.1007\/s40256-024-00661-5","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338060-comparison-of-clinical-factors-between-recurrent-and-non-recurrent-atrial-fibrillation-within-one-year-after-catheter-ablation-by-the-same-operators-at-a-regional-core-hospital-in-japan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:13:32Z","timestamp":1759022012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338060-comparison-of-clinical-factors-between-recurrent-and-non-recurrent-atrial-fibrillation-within-one-year-after-catheter-ablation-by-the-same-operators-at-a-regional-core-hospital-in-japan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.93365","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,27]]}}}